Last Chance Learning: Expiring Soon
Maximize Your Learning Opportunity! Explore our curated selection of courses expiring soon on FreeCME.com. Don't miss out on valuable educational content tailored to your professional development. Hurry, these courses won't be available for long. Enrich your knowledge and earn CME credits today!
![480x360 mced](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/480x360-mced.png 496w)
TOP 10 Early Cancer Detection Queries: What You Need to Know About Blood-Based Screening in Primary Care
CME: 0.5
View Course
![A1113 Journal 2 Free CME 496x244 NOTEXT](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/A1113-Journal-2-FreeCME-496x244-NOTEXT.jpg 496w)
Updates on HER3-DXd Treatment of Metastatic Breast Cancer
CME: 0.25
View Course
![A1203 other 460x360](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/a1203_other_460x360.jpg 496w)
Exploring the Role of Pathophysiology of IDH-Mutant Gliomas on Current and Emerging Treatments
CME: 1
View Course
![Gettyimages 530684771](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/gettyimages-530684771.jpg 496w)
Virtual Practice Managing Immune-Related Adverse Events (irAEs) in Simulated Scenarios
CME: 0.5
View Course
![Hemo picture for freecme 2](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/hemo_picture_for_freecme_2.jpeg 496w)
Clinical Updates in Chronic Graft-versus-Host Disease and Applications for Academic and Community Practice
CME: 0.5
View Course
![Platformqibd](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/platformqibd.jpg 496w)
Equity in UC Care: Listening to Patients and Integrating Novel Therapies to Induce and Maintain Remission
CME: 1
View Course
![Optimizing hcv screening blurb image](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/optimizing_hcv_screening_blurb_image.png 496w)
Optimizing HCV Screening and Treatment in Rural and Underserved Communities: Patient Perspectives and Expert Insight – Part 1
CME: 1
View Course
![Screenshot 2023 12 29 103750](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/screenshot_2023-12-29_103750.jpg 496w)
Advancing Equity in Inflammatory Bowel Disease Care: Evidence-Based Strategies for Improving Recognition and Management in Rural and Underserved Communities
CME: 1
View Course
![Screenshot 2023 12 19 094606](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/screenshot_2023-12-19_094606.jpg 496w)
Improving Recognition and Management of Myelodysplastic Syndromes in Rural and Underserved Communities: A Primary Care Approach
CME: 1
View Course
![Picture1 1](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/picture1_1.png 496w)
Optimizing Short Bowel Syndrome Management in Rural and Underserved Settings: Patient Insight and Collaborative Pathways for Delivering Evidence-Based Care
CME: 1
View Course
![Imageforfreecme 1](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/imageforfreecme_1.png 496w)
Managing Children and Adults With Moderate-to-Severe Atopic Dermatitis: Addressing Treatment Challenges and Improving Access to Care in Rural and Underserved Communities
CME: 1
View Course
![Image for blurb](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/image_for_blurb.jpg 496w)
The Importance of Early Recognition of Tay-Sachs and Sandhoff Disease
CME: 0.75
View Course
![480x360 ild decision making tool](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/480x360_ild_decision_making_tool.png 496w)
Bridging Specialties™: Timely Diagnosis for ILD
CME: 0.5
View Course
![Blurbforimage 1](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/blurbforimage_1.jpg 496w)
Right Treatment, Right Patient: Evidence-Based Approaches to the Treatment of Moderate-to-Severe Atopic Dermatitis Snippet 3: Emerging Injectable Biologic Therapies for Moderate-to-Severe Atopic Dermatitis (AD)
CME: 0.25
View Course
![A1138 case consult 4 other 480x360](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/a1138_case_consult_4_other_480x360.jpg 496w)
Case Consult: 25-Year-Old Man With Newly Diagnosed HeFH
CME: 0.25
View Course